Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.

Clinical trial NCT00766545 · COMPLETED

Trial details

NCT number: NCT00766545
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cerebral Infarction

Start date: 1992-04-01
Primary completion: 1997-03-01
Enrollment: 1095

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.